Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
Holding NWBO?
Track your performance easily

Northwest Biotherapeutics (NWBO) Financial Statements

415 Followers

Northwest Biotherapeutics Financial Overview

Northwest Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-0.063; its P/E ratio is -4.46; Northwest Biotherapeutics is scheduled to report earnings on May 16, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 357.00K$ 510.00K$ 284.00K$ 445.00K$ 406.00K
Gross Profit$ 357.00K$ 510.00K$ 284.00K$ 445.00K$ 406.00K
EBIT$ -17.27M$ -16.17M$ -18.46M$ -17.68M$ -16.91M
EBITDA$ -16.20M$ -15.16M$ -17.38M$ -17.26M$ -16.42M
Net Income Common Stockholders$ -19.51M$ -18.31M$ -18.88M$ -19.26M$ -19.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.94M$ 2.88M$ 2.48M$ 2.13M$ 6.10M
Total Assets$ 29.32M$ 28.23M$ 28.57M$ 27.86M$ 31.49M
Total Debt$ 35.18M$ 37.81M$ 32.58M$ 32.79M$ 27.19M
Net Debt$ 32.24M$ 34.93M$ 30.10M$ 30.66M$ 21.09M
Total Liabilities$ 93.56M$ 85.97M$ 82.04M$ 74.92M$ 68.94M
Stockholders Equity$ -80.12M$ -76.50M$ -73.28M$ -65.77M$ -65.12M
Cash Flow-
Free Cash Flow$ -8.41M$ -16.72M$ -12.64M$ -17.38M$ -14.36M
Operating Cash Flow$ -8.23M$ -16.20M$ -12.41M$ -16.96M$ -13.92M
Investing Cash Flow$ -176.00K$ -521.00K$ -239.00K$ -418.00K$ -437.00K
Financing Cash Flow$ 11.62M$ 17.14M$ 12.09M$ 14.41M$ 17.12M
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

Northwest Biotherapeutics Debt to Assets

Northwest Biotherapeutics Cash Flow

Northwest Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis